Retinoid-related orphan receptor γt is a potential therapeutic target for controlling inflammatory autoimmunity

Expert Opinion on Therapeutic Targets

Volumn 11, Issue 6, 2007, Pages 737-743

  Huang, Zhaofeng ^a   Xie, Huimin ^a   Wang , Ruiqing ^a   Sun, Zuoming ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Autoimmunity; Bcl xL; IL 17; Inflammation; ROR t; T cell; TH17

Indexed keywords

CELL NUCLEUS RECEPTOR; INTERLEUKIN 17; RETINOID RELATED ORPHAN RECEPTOR GAMMA T; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL ACTIVITY; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOKINE PRODUCTION; HELPER CELL; HUMAN; IMMUNOREGULATION; INFLAMMATION; LYMPH NODE; NONHUMAN; PEYER PATCH; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SEQUENCE ANALYSIS; T LYMPHOCYTE; TH17 CELL; THYMOCYTE; TISSUE INJURY; TRANSCRIPTION REGULATION;

ANIMALS; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; DRUG DELIVERY SYSTEMS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-17; RECEPTORS, RETINOIC ACID; RECEPTORS, THYROID HORMONE; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 34250192169     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.11.6.737     Document Type: Review

References (64)

1. EBERL G, MARMON S, SUNSHINE MJ et al.: An essential function for the nuclear receptor RORγ(t) in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. (2004) 5(1):64-73.
2. + cells. Science (2004) 305(5668):248-251.
3. SUN Z, UNUTMAZ D, ZOU YR et al.: Requirement for RORγ in thymocyte survival and lymphoid organ development. Science (2000) 288(5475):2369-2373.
4. KUREBAYASHI S, NAKAJIMA T, KIM SC et al.: Selective LXXLL peptides antagonize transcriptional activation by the retinoid-related orphan receptor RORγ. Biochem. Biophys. Res. Commun. (2004) 315(4):919-927.
5. XIE H, SADIM MS, SUN Z: RORγt recruits steroid receptor coactivators to ensure thymocyte survival. J. Immunol. (2005) 175(6):3800-3809.
6. HEERY DM, KALKHOVEN E, HOARE S, PARKER MG: A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature (1997) 387(6634):733-736.
7. ONATE SA, BOONYARATANAKORNKIT V, SPENCER TE et al.: The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1(AF1) and AF2 domains of steroid receptors. J. Biol. Chem. (1998) 273(20):12101-12108.
8. MCKENNA NJ, XU J, NAWAZ Z et al.: Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J. Steroid Biochem. Mol. Biol. (1999) 69(1-6):3-12.
9. GLASS CK, ROSENFELD MG: The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. (2000) 14(2):121-141.
10. VOEGEL JJ, HEINE MJ, TINI M et al.: The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J. (1998) 17(2):507-519.
11. KUREBAYASHI S, UEDA E, SAKAUE M et al.: Retinoid-related orphan receptor γ (RORγ) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis. Proc. Natl. Acad. Sci. USA (2000) 97(18):10132-10137.
12. EBERL G, LITTMAN DR. The role of the nuclear hormone receptor RORγt in the development of lymph nodes and Peyer's patches. Immunol. Rev. (2003) 195:81-90.
13. ROUVIER E, LUCIANI MF, MATTEI MG, DENIZOT F, GOLSTEIN P: CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J. Immunol. (1993) 150(12):5445-5456.
14. YAO Z, PAINTER SL, FANSLOW WC et al.: Human IL-17: a novel cytokine derived from T cells. J. Immunol. (1995) 155(12):5483-5486.
15. HARRINGTON LE, MANGAN PR, WEAVER CT: Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr. Opin. Immunol. (2006) 18(3):349-356.
16. + effector T cells develop via a lineage distinct from the T helper Type 1 and 2 lineages. Nat. Immunol. (2005) 6(11):1123-1132.
17. PARK H, LI Z, YANG XO et al.: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. (2005) 6(11):1133-1141.
18. STARNES T, ROBERTSON MJ, SLEDGE G et al.: Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J. Immunol. (2001) 167(8):4137-4140.
19. FORT MM, CHEUNG J, YEN D et al.: IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity (2001) 15(6):985-995.
20. LEE J, HO WH, MARUOKA M et al.: IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J. Biol. Chem. (2001) 276(2):1660-1664.
21. LI H, CHEN J, HUANG A et al.: Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc. Natl. Acad. Sci. USA (2000) 97(2):773-778.
22. STARNES T, BROXMEYER HE, ROBERTSON MJ, HROMAS R: Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J. Immunol. (2002) 169(2):642-646.
23. LANGRISH CL, CHEN Y, BLUMENSCHEIN WM et al.: IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. (2005) 201(2):233-240.
24. BETTELLI E, KUCHROO VK: IL-12- and IL-23-induced T helper cell subsets: birds of the same feather flock together. J. Exp. Med. (2005) 201(2):169-171,
25. CUA DJ, SHERLOCK J, CHEN Y et al.: Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature (2003) 421(6924):744-748.
26. H17 and regulatory T cells. Nature (2006) 441(7090):235-238.
27. H17 lineage. Nature (2006) 441(7090):231-234.
28. VELDHOEN M, HOCKING RJ, ATKINS CJ, LOCKSLEY RM, STOCKINGER B: TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity (2006) 24(2):179-189.
29. MURPHY CA, LANGRISH CL, CHEN Y et al.: Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. (2003) 198(12):1951-1957.
30. NAKAE S, NAMBU A, SUDO K, IWAKURA Y: Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. (2003) 171(11):6173-6177.
31. NAKAE S, KOMIYAMA Y, NAMBU A et al.: Antigen-specific T cell sensitization is impaired in IL-17-deficicnt mice, causing suppression of allergic cellutar and humoral responses. Immunity (2002) 17(3):375-387.
32. KOMIYAMA Y, NAKAE S, MATSUKI T et al.: IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. (2006) 177(1):566-573.
33. GORELIK L, FLAVELL RA: Transforming growth factor-β in T-cell biology. Nat. Rev. Immunol. (2002) 2(1):46-53.
34. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. (2003) 198(12):1875-1886.
35. + regulatory T cells from human peripheral blood. J. Immunol. (2001) 166(12):7282-7289.
36. WEAVER CT, HARRINGTON LE, MANGAN PR, GAVRIELI M, MURPHY KM: Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity (2006) 24(6):677-688.
37. LUBBERTS E, KOENDERS MI, VAN DEN BERG WB: The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res. Ther. (2005) 7(1):29-37.
38. LINDEN A: Interleukin-17 and airway remodelling. Pulm. Pharmacol. Ther. (2006) 19(1):47-50.
39. FUJINO S, ANDOH A, BAMBA S et al.: Increased expression of interleukin 17 in inflammatory bowel disease. Gut (2003) 52(1):65-70.
40. MATUSEVICIUS D, KIVISAKK P, HE B et al.: Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler. (1999) 5(2):101-104.
41. + T helper cells. Cell (2006) 126(6):1121-1133.
42. LAAN M, CUI ZH, HOSHINO H et al.: Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J. Immunol. (1999) 162(4):2347-2352.
43. LAAN M, PALMBERG L, LARSSON K, LINDEN A: Free, soluble interleukin-17 protein during severe inflammation in human airways. Eur. Respir. J. (2002) 19(3):534-537.
44. LAAN M, LOTVALL J, CHUNG KF, LINDEN A: IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases. Br. J. Pharmacol. (2001) 133(1):200-206.
45. SCHWARZENBERGER P, LA RUSSA V, MILLER A et al.: IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J. Immunol. (1998) 161(11):6383-6389.
46. YE P, GARVEY PB, ZHANG P et al.: Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am. J. Respir. Cell Mol. Biol. (2001) 25(3):335-340.
47. LOCKHART E, GREEN AM, FLYNN JL: IL-17 production is dominated by γδ T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. (2006) 177(7):4662-4669.
48. YE P, RODRIGUEZ FH, KANALY S et al.: Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. (2001) 194(4):519-527.
49. NOVELLI F, CASANOVA JL: The role of IL-12, IL-23 and IFN-γ in immunity to viruses. Cytokine Growth Factor Rev. (2004) 15(5):367-377.
50. FIESCHI C, CASANOVA JL: The role of interleukin-12 in human infectious diseases: only a faint signature. Eur. J. Immunol. (2003) 33(6):1461-1464.
51. KASTELEIN RA, HUNTER CA, CUA DJ: Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Ann. Rev. Immunol. (2007) 25:221-242.
52. + γδ T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. (2007) 178(7):4466-4472.
53. HE YW, DEFTOS ML, OJALA EW, BEVAN MJ: RORγτ, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity (1998) 9(6):797-806.
54. TILLEY SL, JARADAT M, STAPLETON C et al.: Retinoid-related orphan receptor γ controls immunoglobulin production and Th1/Th2 cytokine balance in the adaptive immune response to allergen. J. Immunol. (2007) 178(5):3208-3218.
55. KOLLS JK, LINDEN A: Interleukin-17 family members and inflammtion. Immunity (2004) 21(4):467-476.
56. WARE CF: NETWORK COMMUNICATIONS: Lymphotoxins, LIGHT, and TNF. Ann. Rev. Immunol. (2005) 23(1):787-819.
57. NISHIMOTO N, KISHIMOTO T: Interleukin 6: from bench to bedside. Nat. Clin. Pract. Rheumatol. (2006) 2(11):619-626.
58. KIKLY K, LIU L, NA S, SEDGWICK JD: The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr. Opin. Immunol. (2006) 18(6):670-675.
59. VAKNIN-DEMBINSKY A, BALASHOV K, WEINER HL: IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J. Immunol. (2006) 176(12):7768-7774.
60. BOWMAN EP, CHACKERIAN AA, CUA DJ: Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy. Curr. Opin. Infect. Dis. (2006) 19(3):245-252.
61. EGAWA T, EBERL G, TANIUCHI I et al.: Genetic evidence supporting selection of the Vα14i NKT cell lineage from double-positive thymocyte precursors. Immunity (2005) 22(6):705-716.
62. JETTEN AM: Recent advances in the mechanisms of action and physiological functions of the retinoid-related orphan receptors (RORs). Curr. Drug Targets Inflamm. Allergy (2004) 3(4):395-412.
63. JETTEN AM, JOO JH: Retinoid-related orphan receptor (ROR)γ: roles in celluar differentiation and development. Adv. Dev. Biol. (2006) 16:314-354.
64. UEDA E, KUREBAYASHI S, SAKAUE M et al.: High incidence of T-cell lymphomas in mice deficient in the retinoid-related orphan receptor RORγ. Cancer Res. (2002) 62(3):901-909.